Press release
Global Radiopharmaceuticals Market To Be Driven By Increasing Prevalence Of Cancer And Cardiovascular Diseases In The Forecast Period 2022-2031: Siemens Healthcare Private Limited, Bayer, GE Healthcare, Novartis AG
Radiopharmaceuticals Market
https://www.thebusinessresearchcompany.com/opportunities-and-strategies-reports
The global radiopharmaceuticals market report by the business research company identifies the increasing prevalence of cancer and cardiovascular diseases to be a major growth driver for the radiopharmaceuticals market. Radiopharmaceuticals are emerging as a safe and effective therapeutic option over conventional medicines. Radiopharmaceuticals provide an upper hand to radiologists to treat cancer and cardiovascular diseases due to their benefits such as targeted therapy. Cancer is considered to be the second major cause of death, with around 1 in 6 deaths due to cancer worldwide.
The global radiopharmaceuticals market is expected to grow from $5.63 billion in 2021 to $5.90 billion in 2022 at a compound annual growth rate (CAGR) of 4.7%. The radiopharmaceuticals market is expected to reach $7.30 billion in 2026 at a CAGR of 5.5%.
Purchase The Radiopharmaceuticals Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3471
North America was the largest region in the radiopharmaceuticals market in 2021. Middle East is expected to be the fargest growing region in the forecast period. The regions covered in the radiopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Major players in the radiopharmaceuticals market are
The global radiopharmaceuticals market is segmented -
1) By Type: Diagnostic, Therapeutic, Others
2) By Application: Oncology, Cardiology, Gastroenterology, Neuroendocrinnology, Neurology, Nephrology, Others
3) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes, Others
Request A Free Sample Of The Radiopharmaceuticals Market Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3471&type=smp
The Radiopharmaceuticals Market Report Contents Include
1. Executive Summary
2. Radiopharmaceuticals Market Characteristics
3. Radiopharmaceuticals Market Trends And Strategies
4. Radiopharmaceuticals Market - Macro Economic Scenario
5. Radiopharmaceuticals Market Size And Growth
.....
27. Radiopharmaceuticals Market Competitive Landscape And Company Profiles
22. Key Mergers And Acquisitions In The Radiopharmaceuticals Market
28. Radiopharmaceuticals Pipeline Analysis
29. Key Mergers And Acquisitions In The Radiopharmaceuticals Market
30. Radiopharmaceuticals Market Future Outlook and Potential Analysis
31. Appendix
This report covers the trends and market dynamics of the radiopharmaceuticals market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Check out our:
TBRC Blog: http://blog.tbrc.info/
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Healthcare Blog: https://healthcareresearchreports.com/
About Us:
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. It has published over 3000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Radiopharmaceuticals Market To Be Driven By Increasing Prevalence Of Cancer And Cardiovascular Diseases In The Forecast Period 2022-2031: Siemens Healthcare Private Limited, Bayer, GE Healthcare, Novartis AG here
News-ID: 2824029 • Views: …
More Releases from The Business research company
Autotransfusion Devices Market Report 2024-2033 | Share, Trends, Growth Demand, …
The autotransfusion devices market size has grown strongly in recent years. It will grow from $1.17 billion in 2023 to $1.24 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to increase in surgical procedures, cardiovascular disease prevalence, orthopedic surgeries and joint replacements, focus on patient safety, efforts to reduce blood transfusion costs.
The autotransfusion devices market…
Checkpoint Inhibitors Global Market Report 2024 - By Share, Size, Demand, Trends …
The checkpoint inhibitors market size has grown rapidly in recent years. It will grow from $32.41 billion in 2023 to $37.88 billion in 2024 at a compound annual growth rate (CAGR) of 16.9%. The growth in the historic period can be attributed to rising incidence of cancer, increasing awareness of checkpoint inhibitors, expanding range of approved checkpoint inhibitors, research and development on checkpoints novel inhibitors, clinical trials…
Acute Ischemic Stroke Drugs Market Report Size, Share, Trends And Growth Forecas …
The acute ischemic stroke drugs market size has grown strongly in recent years. It will grow from $13.01 billion in 2023 to $13.66 billion in 2024 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to increasing incidence of stroke, government initiatives and healthcare policies, increased awareness and education, strategic collaborations and partnerships, aging population.
The acute ischemic stroke drugs…
Bluetooth 5.0 Market 2024 - Growth Analysis, Opportunities, Business Insights, K …
The bluetooth 5.0 market size has grown rapidly in recent years. It will grow from $4.42 billion in 2023 to $4.96 billion in 2024 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to increased data transfer speed, extended range, enhanced data broadcasting, higher throughput for audio streaming, low energy consumption.
The bluetooth 5.0 market size is expected to see…
More Releases for Radiopharmaceuticals
Nuclear Medicine/Radiopharmaceuticals Market Growing by Convenience of Radiophar …
Nuclear Medicine/Radiopharmaceuticals Market Outlook 2022-2029
The Nuclear Medicine/Radiopharmaceuticals Market research offers complete knowledge and information on the market's flowing landscape, what is now available on the market, upcoming trends, market expectations, the competitive environment, and methods that may be used to outperform competitors.
Market Analysis and Size
The Nuclear Medicine/Radiopharmaceuticals Market is currently valued at US$ 10.16 Billion and is projected to register 9.90% CAGR through 2029.
Gets a Sample Copy of the Nuclear…
Diagnostic Radiopharmaceuticals Market 2021 | Detailed Report
According to Market Study Report, Diagnostic Radiopharmaceuticals Market provides a comprehensive analysis of the Diagnostic Radiopharmaceuticals Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of Diagnostic Radiopharmaceuticals Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4645020
The report provides a comprehensive analysis of…
Global Radiopharmaceuticals Market 2017-2021
About Radiopharmaceuticals
Radiopharmaceuticals are pharmaceutical drugs having radioactive properties. The drugs can be used for therapeutic and diagnostic purposes. It is made up of radioisotope that bonds to an organic molecule. The radiopharmaceuticals find large application in the medical field due to their intrinsic properties. The radiopharmaceutical market is expected to benefit from the growing demand from the cancer market. Cancer is one of the major segments having a huge demand…
Global Radiopharmaceuticals Market Global Radiopharmaceuticals Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Global Radiopharmaceutical Market Overview
1.1 Current Market Scenario
1.2 Diagnostic & Therapeutic Radiopharmaceuticals
1.3 Global Radiopharmaceticals Clinical Pipeline Overview
2. Global Radiopharmaceuticals Market Dynamics
3. Radioisotopes Used in Radiopharmaceuticals
4. EMA Guidelines for Radiopharmaceuticals
4.1 Physico-Chemical, Biological or Microbiological Tests of Medicinal Products
4.2 Toxicological & Pharmacological Tests
4.3 Clinical Documentation
4.4 Radiation…
Nuclear Medicine/Radiopharmaceuticals Market
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use…
Global Radiopharmaceuticals Market Insight
Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a…
